A PYMNTS Company

U.S.: FTC backs pharma co in fight to sell generics

By  |  November 28, 2012

The Federal Trade Commission is backing pharmaceutical company Mylan Pharmaceuticals, based in Pennsylvania, in its efforts to bring charges against Warner Chilcott Plc, whose headquarters reside in New Jersey. Three class action suits have been filed against Warner Chilcott in addition to Mylan’s suit, which alleges that Warner Chilcott was hampering competition by preventing Mylan from selling a generic antibacterial drug. While the drug is made by Warner Chilcott, Mylan says that Warner Chilcott was preventing the sale of the generic and instead pushing for the sale of another version of the drug that Warner Chilcott sells itself, which Mylan says was different but not “better.”

Full Content: Philly.com

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.